City of Hope presents new research on cancer immunotherapies at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Data on combination checkpoint inhibitor therapy for lymphoma, natural killer cells for leukemia and chimeric antigen receptor (CAR) T therapy for prostate cancer will be presented at June 2 to 6 meeting in Chicago LOS ANGELES, May 22, 2023 /PRNewswire/ — City of Hope, one of the largest…